DCO Stock Analysis: Ducommun | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 2.715m USD | 12M Return: 102.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 49.8M
EPS Trend: 89.0%
Qual. Beats: 0
Rev. Trend: 98.1%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ducommun Incorporated (NYSE: DCO) is a U.S.-based provider of engineering and manufacturing services serving the aerospace and defense, industrial, medical, and other end markets. The company operates through two segments: Electronic Systems, which produces cable and interconnect assemblies, printed circuit board assemblies, electromechanical components, RF and microwave switches and filters, and offers aerospace systems engineering and integration services; and Structural Systems, which designs and manufactures complex contoured aerostructure components, including composite and metal bonded structures, winglets, engine components, fuselage skins, rotor blades, and ammunition handling systems. Customers span commercial aircraft, military fixed-wing, military and commercial rotary-wing platforms, and space programs.
The business operates as a contract aerospace supplier delivering engineered components and subassemblies to aircraft OEMs and defense prime contractors, with manufacturing capability spanning electronic, composite, and metallic aerostructures. Founded in 1849 and headquartered in Costa Mesa, California, Ducommun is classified within the GICS Industrials sector and Aerospace & Defense sub-industry.
- Defense backlog expands on military aircraft and space programs
- Structural Systems margins pressured by aluminum and titanium input costs
- Electronic Systems acquisitions add higher-margin defense content
| Net Income: -32.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -5.07 > 1.0 |
| NWC/Revenue: 54.85% < 20% (prev 51.30%; Δ 3.56% < -1%) |
| CFO/TA -0.02 > 3% & CFO -22.9m > Net Income -32.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.6m) vs 12m ago 2.78% < -2% |
| Gross Margin: 26.84% > 18% (prev 25.57%; Δ 1.27% > 0.5%) |
| Asset Turnover: 72.69% > 50% (prev 69.98%; Δ 2.71% > 0%) |
| Interest Coverage Ratio: -6.87 > 6 (EBIT TTM -37.1m / Interest Expense TTM 5.40m) |
| A: 0.39 (Total Current Assets 633.9m - Total Current Liabilities 172.6m) / Total Assets 1.19b |
| B: 0.35 (Retained Earnings 416.2m / Total Assets 1.19b) |
| C: -0.03 (EBIT TTM -37.1m / Avg Total Assets 1.16b) |
| D: 1.30 (Book Value of Equity 669.8m / Total Liabilities 515.5m) |
| Altman-Z'' = 4.85 = AA |
| DSRI: 1.10 (Receivables 386.3m/330.1m, Revenue 841.0m/789.8m) |
| GMI: 0.95 (GM 25.57% / 26.84%) |
| AQI: 0.94 (AQ_t 0.34 / AQ_t-1 0.37) |
| SGI: 1.06 (Revenue 841.0m / 789.8m) |
| TATA: -0.01 (NI -32.7m - CFO -22.9m) / TA 1.19b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of July 10, 2026, the stock is trading at USD 170.84 with a total of 337,446 shares traded. Over the past week, the price has changed by -10.20%, over one month by +9.32%, over three months by +21.52% and over the past year by +102.25%.
Current recommended Stop Loss: 149.60 (which is 12.4% or 2.7 ATR below the current price).
Ducommun has received a consensus analysts rating of 4.60. Therefore, it is recommended to buy DCO.
- StrongBuy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 173.8 | 1.7% |
P/E Forward = 41.3223
P/S = 3.2264
P/B = 4.2027
P/EG = 1.3126
Revenue TTM = 841.0m USD
EBIT TTM = -37.1m USD
EBITDA TTM = -3.82m USD
Long Term Debt = 297.6m USD (from longTermDebt, last quarter)
Short Term Debt = 12.0m USD (from shortTermDebt, last quarter)
Debt = 382.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 40.1m
Net Debt = 343.7m USD (calculated: Debt 382.8m - CCE 39.1m)
Enterprise Value = 3.06b USD (2.71b + Debt 382.8m - CCE 39.1m)
Interest Coverage Ratio = -6.87 (Ebit TTM -37.1m / Interest Expense TTM 5.40m)
EV/FCF = -84.26x (Enterprise Value 3.06b / FCF TTM -36.3m)
FCF Yield = -1.19% (FCF TTM -36.3m / Enterprise Value 3.06b)
FCF Margin = -4.32% (FCF TTM -36.3m / Revenue TTM 841.0m)
Net Margin = -3.88% (Net Income TTM -32.7m / Revenue TTM 841.0m)
Gross Margin = 26.84% ((Revenue TTM 841.0m - Cost of Revenue TTM 615.3m) / Revenue TTM)
Gross Margin QoQ = 26.90% (prev 27.28%)
Tobins Q-Ratio = 2.58 (Enterprise Value 3.06b / Total Assets 1.19b)
Interest Expense / Debt = 1.41% (Interest Expense 5.40m / Debt 382.8m)
Taxrate = 15.32% (1.79m / 11.7m)
NOPAT = -31.4m (EBIT -37.1m * (1 - 15.32%)) [loss with tax shield]
Current Ratio = 3.67 (Total Current Assets 633.9m / Total Current Liabilities 172.6m)
Debt / Equity = 0.57 (Debt 382.8m / totalStockholderEquity, last quarter 669.8m)
Debt / EBITDA = -89.95 (negative EBITDA) (Net Debt 343.7m / EBITDA -3.82m)
Debt / FCF = -9.47 (negative FCF - burning cash) (Net Debt 343.7m / FCF TTM -36.3m)
Total Stockholder Equity = 672.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.82% (Net Income -32.7m / Total Assets 1.19b)
RoE = -4.86% (Net Income TTM -32.7m / Total Stockholder Equity 672.2m)
RoCE = -3.83% (EBIT -37.1m / Capital Employed (Equity 672.2m + L.T.Debt 297.6m))
RoIC = -3.19% (negative operating profit) (NOPAT -31.4m / Invested Capital 985.7m)
WACC = 8.21% (E(2.71b)/V(3.10b) * Re(9.20%) + D(382.8m)/V(3.10b) * Rd(1.41%) * (1-Tc(0.15)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.56 | Cagr: 2.09%
[DCF] Fair Price = unknown (Cash Flow -36.3m)
EPS Correlation: 89.00 | EPS CAGR: 13.48% | SUE: 0.25 | # QB: 0
Revenue Correlation: 98.10 | Revenue CAGR: 4.10% | SUE: 3.74 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.98 | Chg30d=+0.59% | Revisions=-12% | Analysts=5
EPS next Quarter (2026-09-30): EPS=1.16 | Chg30d=+0.16% | Revisions=-57% | Analysts=5
EPS current Year (2026-12-31): EPS=4.15 | Chg30d=+0.27% | Revisions=-38% | GrowthEPS=+10.7% | GrowthRev=+7.1%
EPS next Year (2027-12-31): EPS=5.11 | Chg30d=+0.57% | Revisions=-38% | GrowthEPS=+23.1% | GrowthRev=+9.1%
[Analyst] Revisions Ratio: -50% (up=4, down=15)